denalitherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Sitemap: https://www.denalitherapeutics.com/sitemap.xml User-agent: * Disallow: /user/ Disallow: /taxonomy/ Disallow: /cohesionapi/ Disallow: /ajax_machine_name/ Disallow: /image-gallery/ Disallow: /lightbox/ Disallow: /search/node/ Disallow: /investors/press-release Disallow: | ||
Meta Tags
| Title | Denali | |
| Description | Defeat Feb 12th Webinar: Denali Transport Vehicle (TV) Technology: DNL310 (ETV:IDS) Ph1/2 Cohort A Interim Data in Hunter Syndrome Patients × Home + Scientific A |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 44.235.178.77 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
denalitherapeutics.com Valuation
|
US$42,703,954
Last updated: 2023-04-28 20:28:28
denalitherapeutics.com has Semrush global rank of 247,853. denalitherapeutics.com has an estimated worth of US$ 42,703,954, based on its estimated Ads revenue. denalitherapeutics.com receives approximately 4,927,380 unique visitors each day. Its web server is located in United States, with IP address 44.235.178.77. According to SiteAdvisor, denalitherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$42,703,954 |
| Daily Ads Revenue | US$39,420 |
| Monthly Ads Revenue | US$1,182,572 |
| Yearly Ads Revenue | US$14,190,853 |
| Daily Unique Visitors | 328,492 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| denalitherapeutics.com. | A | 600 | IP: 44.235.178.77 |
| denalitherapeutics.com. | A | 600 | IP: 52.37.201.116 |
| denalitherapeutics.com. | A | 600 | IP: 44.234.240.195 |
| denalitherapeutics.com. | NS | 3600 | NS Record: ns30.domaincontrol.com. |
| denalitherapeutics.com. | NS | 3600 | NS Record: ns29.domaincontrol.com. |
| denalitherapeutics.com. | MX | 3600 | MX Record: 0 smtp.secureserver.net. |
| denalitherapeutics.com. | MX | 3600 | MX Record: 10 mailstore1.secureserver.net. |
| denalitherapeutics.com. | TXT | 600 | TXT Record: apple-domain-verification=2Q1mshKuyf2glsfT |
| denalitherapeutics.com. | TXT | 600 | TXT Record: google-site-verification=RGBJZ525slXtTpxUOXb_GSVwZO_zRQcGNJ8X7osa2HE |
| denalitherapeutics.com. | TXT | 600 | TXT Record: v=spf1 include:mailgun.org ~all |
HtmlToTextCheckTime:2023-04-28 20:28:28
| Feb 12th Webinar: Denali Transport Vehicle (TV) Technology: DNL310 (ETV:IDS) Ph1/2 Cohort A Interim Data in Hunter Syndrome Patients × Home + Scientific Approach Genetic Pathway Potential Engineering Brain Delivery Biomarker-Driven Development Publications Pipeline Patients + Investor & Media Relations Press Releases Events SEC Filings Corporate Governance Analyst Coverage Leadership Partnering + Careers Job openings STEM Outreach Overview Student Internships Postdoc Program Contact Defeat Degeneration Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is dedicated to defeating neurodegenerative diseases through rigorous therapeutic discovery and development. The Time is Right Recent groundbreaking scientific insights into the genetic causes and biological processes underlying neurodegenerative diseases offer an unprecedented opportunity for the discovery and development of effective medicines for Alzheimer’s disease, Parkinson’s |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 20:33:52 GMT Server: Apache Location: https://www.denalitherapeutics.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 content-type: text/html content-length: 41899 last-modified: Fri, 08 Oct 2021 18:55:03 GMT accept-ranges: bytes server: AmazonS3 date: Thu, 21 Oct 2021 11:41:42 GMT cache-control: max-age=86400,public etag: "7229a62d882115b04669c927dbc1e662" vary: Accept-Encoding x-cache: Hit from cloudfront via: 1.1 5b5eebc270f0106281bd4e79f778aa3b.cloudfront.net (CloudFront) x-amz-cf-pop: ORD53-C2 x-amz-cf-id: jCHABpPkmejdwysxnpsVt8wBrmToYkMwguRFw6rc3zblJ_J0uV97IA== age: 31931 |
denalitherapeutics.com Whois Information
Domain Name: DENALITHERAPEUTICS.COM Registry Domain ID: 1895428306_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-01-13T12:05:20Z Creation Date: 2015-01-12T14:10:46Z Registry Expiry Date: 2022-01-12T14:10:46Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS29.DOMAINCONTROL.COM Name Server: NS30.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T15:41:36Z <<< |